Shortage reports
Actual shortage:
250 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3299 (93%)
3563
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (12%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2022-03-18 | 2022-04-01 | 156983 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2019-02-13 | 2019-04-22 | 75641 |
| APO-AMLODIPINE-ATORVASTATIN | 40MG 5MG | TABLET | Resolved | 2022-06-06 | 2022-07-22 | 162088 |
| APO-AMLODIPINE-ATORVASTATIN | 20MG 10MG | TABLET | Resolved | 2022-06-12 | 2022-07-22 | 162469 |
| APO-AMLODIPINE-ATORVASTATIN | 40MG 10MG | TABLET | Resolved | 2022-12-02 | 2023-03-02 | 176924 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 40MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119683 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-01-08 | 2020-07-30 | 102528 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2025-08-21 | 2025-09-12 | 265829 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-07-08 | 2020-07-24 | 119693 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-03-04 | 2020-06-24 | 107690 |
| APO-AMOXI | 500MG | CAPSULE | Resolved | 2019-10-23 | 2019-11-05 | 97034 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2022-08-12 | 2024-02-14 | 166621 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2022-06-17 | 2024-02-14 | 162918 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2025-05-08 | 2025-06-20 | 256914 |
| APO-AMOXI | 500MG | CAPSULE | Resolved | 2024-12-05 | 2025-01-03 | 244926 |
| APO-AMOXI | 500MG | CAPSULE | Resolved | 2022-11-27 | 2023-01-06 | 175904 |
| APO-AMOXI | 250MG | CAPSULE | Resolved | 2022-12-05 | 2023-04-14 | 177129 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-11-04 | 2021-01-29 | 127751 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2023-02-23 | 2023-03-16 | 185483 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2022-02-11 | 2022-02-18 | 154749 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SOTALOL - TAB 160MG | 160MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4971 |
| APO-SOTALOL 80MG TABLETS | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61033 |
| APO-SULIN TAB 150MG | 150mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1186 |
| APO-SULIN TAB 200MG | 200MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1172 |
| APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
| APO-TAMOX TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-09-12 | 61050 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40814 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
| APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40811 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-TERAZOSIN | 2MG | TABLET | Discontinued | 2017-03-31 | 2018-02-05 | 4974 |
| APO-TERAZOSIN | 1MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4745 |
| APO-TERAZOSIN | 5MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4749 |